Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Pulmatrix, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 14 | 12 | −2 |
| Shares | 249.5K | 251.6K | +2.10K (+0.8%) |
| Value | $433.5K | $485.6K | +$52.0K (+12.0%) |
New holders (2)
Institutions that held Pulmatrix, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 30 | $58 | 0.00% |
| Gradient Investments LLC | 10 | $19 | 0.00% |
Sold out (4)
Institutions that held Pulmatrix, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| TD Waterhouse Canada Inc. | 350 | $588 |
| Citigroup Inc | 113 | $189 |
| Wells Fargo & Company | 29 | $51 |
| Morgan Stanley | 25 | $44 |